Arecor Therapeutics is a biopharmaceutical company based in the United Kingdom that works on reformulating protein and peptide medicines. Using its own formulation technology, it develops improved versions of existing injectable drugs, including insulin products, with the aim of making them more stable or convenient for patients. The company also partners with other pharmaceutical firms that license its technology, and it advances its own pipeline of treatments for diabetes and other conditions.
Arecor Therapeutics PLC trades under the code AREC on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #921 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
73/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average17.0%
From 52-week high-10.8%
MomentumStrong
82/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return29.9%
6-month return25.0%
12-month, skipping last month18.6%
Stability (higher is calmer)Weak
42/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)35.0%
Worst drawdown, 1 year (smaller is calmer)-37.8%
LiquidityFair
61/100
Moderate trading activity.
See the numbers →
Avg daily value traded2.39M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 55.27 – 95.00Daily closes, split-adjusted
Signals
50-day average74.67
200-day average70.51
Golden/death cross (60d)Golden, 13 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)4.65
Technical summary
Daily
Strongly bullish
12 bullish · 2 neutral · 2 bearish
Weekly
Strongly bullish
10 bullish · 1 neutral · 1 bearish
Monthly
Bullish
5 bullish · 1 neutral · 2 bearish
Moving averages (daily)
SMA 10
76.75
Bullish
EMA 10
78.99
Bullish
SMA 20
79.38
Bullish
EMA 20
78.40
Bullish
SMA 50
74.67
Bullish
EMA 50
75.42
Bullish
SMA 100
69.07
Bullish
EMA 100
72.23
Bullish
SMA 200
70.51
Bullish
EMA 200
70.54
Bullish
Oscillators (daily)
RSI (14)
64.28
Neutral
MACD (12, 26)
0.83
Bullish
Momentum (12)
13.79
Bullish
Stochastic %K (14)
83.33
Bearish
Williams %R (14)
-16.67
Bearish
CCI (20)
27.72
Neutral
Pivot points (classic, last session)
S3
77.23
S2
78.67
S1
80.58
Pivot
82.02
R1
83.93
R2
85.37
R3
87.28
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
